BeyondSpring (BYSI) Divestments (2025)
BeyondSpring (BYSI) posted Divestments of $7.4 million for Q1 2025.
BeyondSpring (BYSI) Divestments (2025) Analysis & Trends
BeyondSpring has reported Divestments for 1 years, with the latest figure at $7.4 million in Q1 2025.
- Quarterly Divestments changed N/A year-over-year to $7.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 million, changed N/A from the prior year.
- Divestments held at $7.4 million in Q1 2025 per BYSI's latest filing.
- Over five years, Divestments peaked at $7.4 million in Q1 2025 and troughed at $7.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - | -13.21 Mn |
| 10 | BeyondSpring | 29.61 Mn | 29.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.35 Mn |